Connect with us

RTS

  •   Vertiv https bit ly 3ObgEub NYSE VRT a global provider of critical digital infrastructure and continuity solutions today introduced the Vertiv Geist Rack Transfer Switch RTS https bit ly 3GcWZbr a new line of transfer switches that provides redundant power to single corded devices and the highly efficient Vertiv Liebert GXT5 Lithium Ion https bit ly 3TC087J uninterruptible power supply UPS designed for rack or stand alone installation These space saving devices are ideal for use in distributed IT networks and edge computing locations and are now available and shipping from stock in Europe Middle East and Africa EMEA The Vertiv Geist RTS instantly detects loss of power and automatically switches the load to an alternative source in less than 4 to 8 milliseconds allowing the supported servers and other critical devices to continue to operate through a planned or unplanned outage It is currently available in basic upgradeable and enhanced intelligence models as well as switched and outlet level monitored models Basic upgradeable models include the intelligence needed today with the option to upgrade technology as needs evolve Enhanced intelligence models provide a comprehensive view of critical IT equipment power usage available either at the rack or via remote access In addition to providing redundant power the Vertiv Geist RTS also proactively monitors the IT environment including temperature humidity and airflow Users have the option to enhance device monitoring features with remote monitoring of IT power usage The Vertiv Geist RTS can support up to 24 outlets for higher density rack configurations Available in 1000VA 1500VA 2000VA and 3000VA capacities the Liebert GXT5 Lithium Ion is a double conversion online UPS which leverages the higher power density of lithium ion to pack more battery runtime in the same amount of space as a typical valve regulated lead acid VRLA battery The Liebert GXT5 Lithium Ion also supports scalable runtime with the ability to add up to eight 1U lithium ion external battery cabinets to each UPS Lithium ion batteries typically last 8 10 years roughly the lifespan of the UPS itself compared to about 3 5 years for VRLA batteries potentially eliminating costly and inconvenient battery replacements and maintenance Lithium ion batteries are also significantly lighter than VRLA batteries and perform better at higher temperatures reducing the expenses and energy required for rack cooling These inherent benefits give Liebert GXT5 Lithium Ion customers a total cost of ownership TCO that is up to 50 lower than a similar UPS using VRLA batteries during the typical life of the UPS Moreover the Liebert GXT5 Lithium Ion features a high power factor 0 9 1 0 and efficiency up to 95 in online mode and up to 98 in active ECO mode enabling further savings on energy and costs As edge computing IoT and 5G continue to expand and become the new backbone of digitalisation distributors and resellers are looking for efficient solutions to protect small and micro IT sites against power outages said Birgit Jackson director integrated racks and IT solutions for Vertiv in EMEA These additions to our IT channel portfolio bring a series of benefits to support growth at the edge of the network enabling businesses to leverage latest technologies and accelerate their digital transformation journey The Vertiv Geist RTS and Liebert GXT5 Lithium Ion UPS are ideal for banking healthcare financial services education energy government and transportation industries that operate micro data centres distributed IT networks or edge computing data centers These latest additions to Vertiv s IT channel portfolio enable EMEA resellers in participating countries to earn more points through the Vertiv Incentive Programme VIP which allows partners to easily win rewards without the need for any reporting Bonus points are uploaded into the Vertiv Partner Portal monthly and the partner only needs to log in to redeem them For more information about Vertiv and its channel portfolio visit Vertiv com https bit ly 3ttnOjY Click on Partners and Apply Now to take full advantage of what Vertiv has to offer
    Vertiv Introduces New Line of Rack Transfer Switches and Lithium-Ion Uninterruptible Power Supply for Distributed Information Technology (IT) and Network Edge Computing Applications in Europe, Middle East and Africa (EMEA)
      Vertiv https bit ly 3ObgEub NYSE VRT a global provider of critical digital infrastructure and continuity solutions today introduced the Vertiv Geist Rack Transfer Switch RTS https bit ly 3GcWZbr a new line of transfer switches that provides redundant power to single corded devices and the highly efficient Vertiv Liebert GXT5 Lithium Ion https bit ly 3TC087J uninterruptible power supply UPS designed for rack or stand alone installation These space saving devices are ideal for use in distributed IT networks and edge computing locations and are now available and shipping from stock in Europe Middle East and Africa EMEA The Vertiv Geist RTS instantly detects loss of power and automatically switches the load to an alternative source in less than 4 to 8 milliseconds allowing the supported servers and other critical devices to continue to operate through a planned or unplanned outage It is currently available in basic upgradeable and enhanced intelligence models as well as switched and outlet level monitored models Basic upgradeable models include the intelligence needed today with the option to upgrade technology as needs evolve Enhanced intelligence models provide a comprehensive view of critical IT equipment power usage available either at the rack or via remote access In addition to providing redundant power the Vertiv Geist RTS also proactively monitors the IT environment including temperature humidity and airflow Users have the option to enhance device monitoring features with remote monitoring of IT power usage The Vertiv Geist RTS can support up to 24 outlets for higher density rack configurations Available in 1000VA 1500VA 2000VA and 3000VA capacities the Liebert GXT5 Lithium Ion is a double conversion online UPS which leverages the higher power density of lithium ion to pack more battery runtime in the same amount of space as a typical valve regulated lead acid VRLA battery The Liebert GXT5 Lithium Ion also supports scalable runtime with the ability to add up to eight 1U lithium ion external battery cabinets to each UPS Lithium ion batteries typically last 8 10 years roughly the lifespan of the UPS itself compared to about 3 5 years for VRLA batteries potentially eliminating costly and inconvenient battery replacements and maintenance Lithium ion batteries are also significantly lighter than VRLA batteries and perform better at higher temperatures reducing the expenses and energy required for rack cooling These inherent benefits give Liebert GXT5 Lithium Ion customers a total cost of ownership TCO that is up to 50 lower than a similar UPS using VRLA batteries during the typical life of the UPS Moreover the Liebert GXT5 Lithium Ion features a high power factor 0 9 1 0 and efficiency up to 95 in online mode and up to 98 in active ECO mode enabling further savings on energy and costs As edge computing IoT and 5G continue to expand and become the new backbone of digitalisation distributors and resellers are looking for efficient solutions to protect small and micro IT sites against power outages said Birgit Jackson director integrated racks and IT solutions for Vertiv in EMEA These additions to our IT channel portfolio bring a series of benefits to support growth at the edge of the network enabling businesses to leverage latest technologies and accelerate their digital transformation journey The Vertiv Geist RTS and Liebert GXT5 Lithium Ion UPS are ideal for banking healthcare financial services education energy government and transportation industries that operate micro data centres distributed IT networks or edge computing data centers These latest additions to Vertiv s IT channel portfolio enable EMEA resellers in participating countries to earn more points through the Vertiv Incentive Programme VIP which allows partners to easily win rewards without the need for any reporting Bonus points are uploaded into the Vertiv Partner Portal monthly and the partner only needs to log in to redeem them For more information about Vertiv and its channel portfolio visit Vertiv com https bit ly 3ttnOjY Click on Partners and Apply Now to take full advantage of what Vertiv has to offer
    Vertiv Introduces New Line of Rack Transfer Switches and Lithium-Ion Uninterruptible Power Supply for Distributed Information Technology (IT) and Network Edge Computing Applications in Europe, Middle East and Africa (EMEA)
    Africa2 weeks ago

    Vertiv Introduces New Line of Rack Transfer Switches and Lithium-Ion Uninterruptible Power Supply for Distributed Information Technology (IT) and Network Edge Computing Applications in Europe, Middle East and Africa (EMEA)

    Vertiv (https://bit.ly/3ObgEub) (NYSE: VRT), a global provider of critical digital infrastructure and continuity solutions, today introduced the Vertiv™ Geist™ Rack Transfer Switch (RTS) (https://bit.ly/3GcWZbr), a new line of transfer switches that provides redundant power to single-corded devices, and the highly-efficient Vertiv™ Liebert® GXT5 Lithium-Ion (https://bit.ly/3TC087J) uninterruptible power supply (UPS), designed for rack or stand-alone installation.

    These space-saving devices are ideal for use in distributed IT networks and edge computing locations, and are now available and shipping from stock in Europe, Middle East and Africa (EMEA).

    The Vertiv Geist RTS instantly detects loss of power and automatically switches the load to an alternative source in less than 4 to 8 milliseconds, allowing the supported servers and other critical devices to continue to operate through a planned or unplanned outage.

    It is currently available in basic upgradeable and enhanced intelligence models, as well as switched and outlet-level monitored models.

    Basic upgradeable models include the intelligence needed today, with the option to upgrade technology as needs evolve.

    Enhanced intelligence models provide a comprehensive view of critical IT equipment power usage, available either at the rack or via remote access.

    In addition to providing redundant power, the Vertiv Geist RTS also proactively monitors the IT environment, including temperature, humidity, and airflow.

    Users have the option to enhance device monitoring features, with remote monitoring of IT power usage.

    The Vertiv Geist RTS can support up to 24 outlets for higher-density rack configurations.

    Available in 1000VA, 1500VA, 2000VA and 3000VA capacities, the Liebert GXT5 Lithium-Ion is a double-conversion, online UPS which leverages the higher power density of lithium-ion to pack more battery runtime in the same amount of space as a typical valve-regulated lead acid (VRLA) battery.

    The Liebert® GXT5 Lithium-Ion also supports scalable runtime with the ability to add up to eight 1U lithium-ion external battery cabinets to each UPS.

    Lithium-ion batteries typically last 8-10 years – roughly the lifespan of the UPS itself – compared to about 3-5 years for VRLA batteries, potentially eliminating costly and inconvenient battery replacements and maintenance.

    Lithium-ion batteries are also significantly lighter than VRLA batteries and perform better at higher temperatures, reducing the expenses and energy required for rack cooling. 

    These inherent benefits give Liebert GXT5 Lithium-Ion customers a total cost of ownership (TCO) that is up to 50% lower than a similar UPS using VRLA batteries, during the typical life of the UPS.

    Moreover, the Liebert GXT5 Lithium-Ion features a high power factor (0.9-1.0) and efficiency up to 95% in online mode and up to 98% in active ECO mode, enabling further savings on energy and costs.

    “As edge computing, IoT and 5G continue to expand and become the new backbone of digitalisation, distributors and resellers are looking for efficient solutions to protect small and micro IT sites against power outages,” said Birgit Jackson, director, integrated racks and IT solutions for Vertiv in EMEA.

    “These additions to our IT channel portfolio bring a series of benefits to support growth at the edge of the network, enabling businesses to leverage latest technologies and accelerate their digital transformation journey.”The Vertiv™ Geist™ RTS and Liebert GXT5 Lithium-Ion UPS are ideal for banking, healthcare, financial services, education, energy, government and transportation industries that operate micro data centres, distributed IT networks or edge computing data centers.

     These latest additions to Vertiv’s IT channel portfolio enable EMEA resellers in participating countries to earn more points through the Vertiv Incentive Programme (VIP), which allows partners to easily win rewards without the need for any reporting.

    Bonus points are uploaded into the Vertiv Partner Portal monthly, and the partner only needs to log in to redeem them.

    For more information about Vertiv and its channel portfolio, visit Vertiv.com (https://bit.ly/3ttnOjY).

    Click on “Partners” and “Apply Now” to take full advantage of what Vertiv has to offer.

  •   Malaria and Child Survival in Nigeria Malaria and Child Survival in Nigeria By Uche Anunne News Agency of Nigeria Health economists estimate that annually billions of dollars are spent in the prevention and treatment of malaria globally A greater chunk of this spending takes place in developing countries The World Health Organistion WHO explains that Malaria is a life threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes adding that it is however preventable and curable According to 2020 World Malaria Report Nigeria is home to the highest number of global malaria cases accounting for 27 per cent of the total number of malaria infections as at 2019 According to the report Nigeria also accounted for 23 per cent of malaria deaths within the year under review with the number of cases increasing by 3 5 per cent between 2016 and 2019 A further demographic breakdown shows that the prevalence rate varies from one region of the country to another with 16 per cent in the south east and south south to 34 per cent in the northwest In a publication Prof Olatunji Kolawole of the Department of Microbiology Faculty of Life Sciences University of Ilorin said Nigerians spend over N300 billion annually on malaria treatments This is figure which comprise governments expenditures and household malaria related medical bills excludes unquantifiable losses in man hours and people stay away from work due to malaria However no matter how huge the financial expenditure on malaria it pales into insignificance compared with the fatalities it causes in malaria endemic countries such as Nigeria While adults have developed mechanisms including regular treatment to deal with malaria it has continued to decimate children killing them in their thousands according to reports According to research published by Malaria Journal under five malaria in Nigeria is a leading cause of global child mortality accounting for 95 000 annual child deaths The journal blames lack of safety nets for the treatment of malaria among infants for the astronomical figure It says that high out of pocket medical expenditure contributes to under five malaria mortality by discouraging care seeking and use of effective anti malarial in the poorest households The World Health Organisation said it is worried by the rate infant mortality arising from malaria and has called for more collaboration to eliminate the disease from around the world Children under five are one of the most vulnerable groups affected by the disease accounting for 67 per cent of all malaria deaths worldwide says Matshidiso Moeti WHO Regional Director for Africa in a statement to mark 2022 World Malaria Day In an earlier report WHO said a child dies every minute from malaria in Africa where it is estimated that 9 out of 10 malaria deaths occur The statistics is not very different from data collation and published by UNICEF on the devastating impact of malaria on children While calling for a joint action UNCEF has many children have continued die as a result of malaria which it said is preventable The regular presence many pregnant women and nursing mothers at health centres and hospitals across the country waiting for treatment from malaria is further indicator to the endemic nature of the problem posed by malaria Every 75 seconds a child under five dies of malaria Many of these deaths are preventable and treatable In 2019 there were 229 million malaria cases globally that led to 558 000 deaths in total Of these deaths 74 per cent 416 000 were children under five years of age This translates into a daily toll of nearly 750 children under age five says the UN agency Mrs Folasade Oguntade Mararaba Nasarawa State based business woman has to spend to ensure that her children are not part of the statistics of children malaria victims The last time I treated my son for malaria I spent N7 000 on drugs for him alone That s just one of my three children You can imagine how much I d spend when I decide to treat all my children against malaria My children don t fall sick that often and I m grateful for that But when they do I have to spend a lot of money she said Governments have responded to the challenge by making malaria testing and treatment part of the antenatal care The current National Malaria Treatment Guideline and Policy in Nigeria recommends intermittent Preventive Treatment IPT using Artemisinin based combination therapy ACT and encourages pregnant women to sleep under Insecticide treated bed nets Experts say sleeping inside insecticide treated bed nets and clean environment can help in addressing the health and socio economic challenges posed by malaria in Nigeria particularly with regards to child mortality The global science community has engaged in researches to find a vaccine for malaria making it of the diseases on queue to join vaccine preventable diseases such wild polio virus and measles In 2019 Kenya Ghana and Malawi were used for the test run of the malaria vaccine known as RTS S Although the final report on the vaccine is not out it is believed to hold a lot of prospects in the fight against malaria and global efforts to save children from the disease The environment plays a role in the manner in which mosquitos breed and Olusegun Ademowo of College of Medicine University of Ibadan contends that only if this is properly addressed efforts to mitigate the impact of malaria will not yield expected results Efforts should be geared towards drastic reduction of contact between humans and mosquitoes Surveillance is a very important component of malaria elimination Environmental management aims to control mosquitoes by removing their breeding sites and larvae This can be done through clearing bushes around the house and other buildings he said NANFeatures If used please credit the writer and News Agency of Nigeria NewsSourceCredit NAN
    Malaria and Child Survival in Nigeria
      Malaria and Child Survival in Nigeria Malaria and Child Survival in Nigeria By Uche Anunne News Agency of Nigeria Health economists estimate that annually billions of dollars are spent in the prevention and treatment of malaria globally A greater chunk of this spending takes place in developing countries The World Health Organistion WHO explains that Malaria is a life threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes adding that it is however preventable and curable According to 2020 World Malaria Report Nigeria is home to the highest number of global malaria cases accounting for 27 per cent of the total number of malaria infections as at 2019 According to the report Nigeria also accounted for 23 per cent of malaria deaths within the year under review with the number of cases increasing by 3 5 per cent between 2016 and 2019 A further demographic breakdown shows that the prevalence rate varies from one region of the country to another with 16 per cent in the south east and south south to 34 per cent in the northwest In a publication Prof Olatunji Kolawole of the Department of Microbiology Faculty of Life Sciences University of Ilorin said Nigerians spend over N300 billion annually on malaria treatments This is figure which comprise governments expenditures and household malaria related medical bills excludes unquantifiable losses in man hours and people stay away from work due to malaria However no matter how huge the financial expenditure on malaria it pales into insignificance compared with the fatalities it causes in malaria endemic countries such as Nigeria While adults have developed mechanisms including regular treatment to deal with malaria it has continued to decimate children killing them in their thousands according to reports According to research published by Malaria Journal under five malaria in Nigeria is a leading cause of global child mortality accounting for 95 000 annual child deaths The journal blames lack of safety nets for the treatment of malaria among infants for the astronomical figure It says that high out of pocket medical expenditure contributes to under five malaria mortality by discouraging care seeking and use of effective anti malarial in the poorest households The World Health Organisation said it is worried by the rate infant mortality arising from malaria and has called for more collaboration to eliminate the disease from around the world Children under five are one of the most vulnerable groups affected by the disease accounting for 67 per cent of all malaria deaths worldwide says Matshidiso Moeti WHO Regional Director for Africa in a statement to mark 2022 World Malaria Day In an earlier report WHO said a child dies every minute from malaria in Africa where it is estimated that 9 out of 10 malaria deaths occur The statistics is not very different from data collation and published by UNICEF on the devastating impact of malaria on children While calling for a joint action UNCEF has many children have continued die as a result of malaria which it said is preventable The regular presence many pregnant women and nursing mothers at health centres and hospitals across the country waiting for treatment from malaria is further indicator to the endemic nature of the problem posed by malaria Every 75 seconds a child under five dies of malaria Many of these deaths are preventable and treatable In 2019 there were 229 million malaria cases globally that led to 558 000 deaths in total Of these deaths 74 per cent 416 000 were children under five years of age This translates into a daily toll of nearly 750 children under age five says the UN agency Mrs Folasade Oguntade Mararaba Nasarawa State based business woman has to spend to ensure that her children are not part of the statistics of children malaria victims The last time I treated my son for malaria I spent N7 000 on drugs for him alone That s just one of my three children You can imagine how much I d spend when I decide to treat all my children against malaria My children don t fall sick that often and I m grateful for that But when they do I have to spend a lot of money she said Governments have responded to the challenge by making malaria testing and treatment part of the antenatal care The current National Malaria Treatment Guideline and Policy in Nigeria recommends intermittent Preventive Treatment IPT using Artemisinin based combination therapy ACT and encourages pregnant women to sleep under Insecticide treated bed nets Experts say sleeping inside insecticide treated bed nets and clean environment can help in addressing the health and socio economic challenges posed by malaria in Nigeria particularly with regards to child mortality The global science community has engaged in researches to find a vaccine for malaria making it of the diseases on queue to join vaccine preventable diseases such wild polio virus and measles In 2019 Kenya Ghana and Malawi were used for the test run of the malaria vaccine known as RTS S Although the final report on the vaccine is not out it is believed to hold a lot of prospects in the fight against malaria and global efforts to save children from the disease The environment plays a role in the manner in which mosquitos breed and Olusegun Ademowo of College of Medicine University of Ibadan contends that only if this is properly addressed efforts to mitigate the impact of malaria will not yield expected results Efforts should be geared towards drastic reduction of contact between humans and mosquitoes Surveillance is a very important component of malaria elimination Environmental management aims to control mosquitoes by removing their breeding sites and larvae This can be done through clearing bushes around the house and other buildings he said NANFeatures If used please credit the writer and News Agency of Nigeria NewsSourceCredit NAN
    Malaria and Child Survival in Nigeria
    Features2 months ago

    Malaria and Child Survival in Nigeria

    Malaria and Child Survival in Nigeria Malaria and Child Survival in Nigeria   By Uche Anunne, News Agency of Nigeria Health economists estimate that annually billions of dollars are spent in the prevention and treatment of malaria globally.

    A greater chunk of this spending takes place in developing countries.

    The World Health Organistion (WHO) explains that “Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes, adding that it is, however,  preventable and curable.

    ” According to 2020 World Malaria Report, Nigeria is home to the highest number of global malaria cases, accounting for 27 per cent of the total number of malaria infections as at 2019. According to the report, Nigeria also accounted for 23 per cent of malaria deaths within the year under review, with the number of cases increasing by 3.5 per cent between 2016 and 2019. A further demographic breakdown shows that the prevalence rate varies from one region of the country to another, with 16 per cent in the south east and south-south to 34 per cent in the northwest.

    In a publication, Prof. Olatunji Kolawole of the Department of Microbiology, Faculty of Life Sciences, University of Ilorin, said Nigerians spend over N300 billion annually on malaria treatments.

    This is figure, which comprise governments expenditures and household malaria-related medical bills excludes unquantifiable losses in man hours and people stay away from work due to malaria.

    However, no matter how huge the financial expenditure on malaria, it pales into insignificance compared with the fatalities it causes in malaria endemic countries such as Nigeria.

    While adults have developed mechanisms, including regular treatment to deal with malaria, it has continued to decimate children, killing them in their thousands, according to reports.

    According to research published by Malaria Journal, under-five malaria in Nigeria is a leading cause of global child mortality, accounting for 95,000 annual child deaths.

    The journal blames lack of safety nets for the treatment of malaria among infants for the astronomical figure.

    It says that: “high out-of-pocket medical expenditure contributes to under-five malaria mortality by discouraging care-seeking and use of effective anti-malarial in the poorest households“.

    The World Health Organisation said it is worried by the rate infant mortality arising from malaria and has called for more collaboration to eliminate the disease from around the world.

    “Children under five are one of the most vulnerable groups affected by the disease, accounting for 67 per cent of all malaria deaths worldwide,” says Matshidiso Moeti, WHO Regional Director for Africa in a statement to mark 2022 World Malaria Day In an earlier report, WHO said a child dies every minute from malaria in Africa where it is estimated that 9 out of 10 malaria deaths occur.

    The statistics is not very different from data collation and published by UNICEF on the devastating impact of malaria on children.

    While calling for a joint action, UNCEF has many children have continued die as a result of malaria which it said is preventable.

    The regular presence many pregnant women and nursing mothers at health centres and hospitals across the country waiting for treatment from malaria is further indicator to the endemic nature of the problem posed by malaria.

    “Every 75 seconds, a child under five dies of malaria.

    Many of these deaths are preventable and treatable.

    “ In 2019, there were 229 million malaria cases globally that led to 558,000 deaths in total.

    Of these deaths, 74 per cent (416,000) were children under five years of age.

    This translates into a daily toll of nearly 750 children under age five”, says the UN agency.

    Mrs Folasade Oguntade, Mararaba, Nasarawa State-based business woman has to spend to ensure that her children are not part of the statistics of children malaria victims.

    “The last time I treated my son for malaria, I spent N7,000 on drugs for him alone.

    That’s just one of my three children.

    “You can imagine how much I’d spend when I decide to treat all my children against malaria.

    My children don’t fall sick that often and I’m grateful for that.

    But when they do, I have to spend a lot of money,” she said.

    Governments have responded to the challenge by making malaria testing and treatment part of the antenatal care.

    The current National Malaria Treatment Guideline and Policy in Nigeria recommends intermittent Preventive Treatment (IPT) using Artemisinin-based combination therapy (ACT) and encourages pregnant women to sleep under Insecticide treated bed nets.

    Experts say sleeping inside insecticide treated bed nets and clean environment can help in addressing the health and socio-economic challenges posed by malaria in Nigeria, particularly with regards to child mortality.

    The global science community has engaged in researches to find a vaccine for malaria, making it of the diseases on queue to join vaccine-preventable diseases such wild polio virus and measles.

    In 2019, Kenya, Ghana and Malawi were used for the test run of the malaria vaccine, known as RTS, S.

    Although the final report on the vaccine is not out, it is believed to hold a lot of prospects in the fight against malaria and global efforts to save children from the disease.

    The environment plays a role in the manner in which mosquitos breed and Olusegun Ademowo of College of Medicine, University of Ibadan contends that only if this is properly addressed efforts to mitigate the impact of malaria will not yield expected results.

    “Efforts should be geared towards drastic reduction of contact between humans and mosquitoes.

    Surveillance is a very important component of malaria elimination.

    “Environmental management aims to control mosquitoes by removing their breeding sites and larvae.

    This can be done through clearing bushes around the house and other buildings,” he said.

    (NANFeatures) **If used please credit the writer and News Agency of Nigeria.  


    NewsSourceCredit: NAN

  •  Mr Peter Hawkins the Country Representative UN Children s Fund UNICEF in Nigeria says the improvement recorded in the number of children immunised against diseases in the country is fantastic He gave the commendation on Sunday during the News Agency of Nigeria Forum in Abuja NAN reports that the National Immunisation Coverage Survey NICS 2021 revealed that 57 per cent of Nigerian children received all three doses of pentavalent vaccines Hawkins said that in spite of the COVID 19 pandemic Nigeria was able to record an improvement in immunisation indices even when some other countries witnessed a drop He added that the situation in Nigeria it s not so much where we are today it s where we have come from In 2016 it was 34 per cent Penta three so three Penta vaccines for a child Now it is at 57 per cent so that improvement is fantastic Over the past three to four years it increased from 50 per cent to 57 per cent So that increase is fantastic in actual fact given that in the middle we had COVID and in most countries immunisation dropped In Nigeria we put a lot of efforts the National Primary Health Care Development Agency NPHCDA puts a lot of effort in maintaining importation of vaccines for routine immunisation maintaining the structures so that they continue to provide vaccination to children and 50 to 57 per cent is a fantastic achievement Hawkins however said that though there was measurable improvement 57 per cent is still insufficient for a country like Nigeria and that the indicators around child mortality demonstrates that According to him the problem is in the fact that some states are performing at a high level while some only record little improvement He added that Lagos State is at 82 per cent if I remember correctly and they have sustained it at that level whereas a state like Sokoto has gone from seven per cent to 11 per cent Eleven per cent is the problem there So it s looking at the states where immunisation is low seeing what the fundamental problems of why and then unbottling those bottlenecks to ensure that they go up to the 57 per cent 60 per cent and ultimately get to 80 per cent He also said that there are communities with zero dose children adding that there are some communities even in Lagos State where immunisation has not reached He explained that the NPHCDA together with Global Alliance for Vaccine Immunisation GAVI and UNICEF have been working hard to ensure that those communities are not left behind He also said that continuous financing for vaccines should be enabled to ensure that the gap is closed For malaria vaccine for children he said it would herald a significant change in child mortality He added that though the vaccine is still expensive it will be included in routine immunisation to prevent children from dying from malaria once they become available We are also coming up with malaria that will be a significant change in the way that the child mortality is looked at The vaccine is still expensive That new vaccine is starting to be developed and once that becomes available for children it will change the dynamic and it s how you include that in the routine immunisation to prevent children from dying from malaria NAN reports that the 2021 World Malaria Report WMR 2021 indicates that Nigeria contributes 27 per cent of the global malaria cases and 32 per cent of global malaria deaths In 2021 the World Health Organisation WHO announced its recommendation of widespread use of the RTS 01 RTS S malaria vaccine among children in sub Saharan Africa and in other regions with moderate to high P falciparum malaria transmission The recommendation was based on results from a pilot programme in Ghana Kenya and Malawi that reached more than 900 000 children since 2019 Though the malaria vaccine is still under review the global target of the World Health Organisation is to reduce the incidence of the disease by at least 30 per cent by 2030 NewsSourceCredit NAN
    Improvement on immunisation in Nigeria fantastic — UNICEF 
     Mr Peter Hawkins the Country Representative UN Children s Fund UNICEF in Nigeria says the improvement recorded in the number of children immunised against diseases in the country is fantastic He gave the commendation on Sunday during the News Agency of Nigeria Forum in Abuja NAN reports that the National Immunisation Coverage Survey NICS 2021 revealed that 57 per cent of Nigerian children received all three doses of pentavalent vaccines Hawkins said that in spite of the COVID 19 pandemic Nigeria was able to record an improvement in immunisation indices even when some other countries witnessed a drop He added that the situation in Nigeria it s not so much where we are today it s where we have come from In 2016 it was 34 per cent Penta three so three Penta vaccines for a child Now it is at 57 per cent so that improvement is fantastic Over the past three to four years it increased from 50 per cent to 57 per cent So that increase is fantastic in actual fact given that in the middle we had COVID and in most countries immunisation dropped In Nigeria we put a lot of efforts the National Primary Health Care Development Agency NPHCDA puts a lot of effort in maintaining importation of vaccines for routine immunisation maintaining the structures so that they continue to provide vaccination to children and 50 to 57 per cent is a fantastic achievement Hawkins however said that though there was measurable improvement 57 per cent is still insufficient for a country like Nigeria and that the indicators around child mortality demonstrates that According to him the problem is in the fact that some states are performing at a high level while some only record little improvement He added that Lagos State is at 82 per cent if I remember correctly and they have sustained it at that level whereas a state like Sokoto has gone from seven per cent to 11 per cent Eleven per cent is the problem there So it s looking at the states where immunisation is low seeing what the fundamental problems of why and then unbottling those bottlenecks to ensure that they go up to the 57 per cent 60 per cent and ultimately get to 80 per cent He also said that there are communities with zero dose children adding that there are some communities even in Lagos State where immunisation has not reached He explained that the NPHCDA together with Global Alliance for Vaccine Immunisation GAVI and UNICEF have been working hard to ensure that those communities are not left behind He also said that continuous financing for vaccines should be enabled to ensure that the gap is closed For malaria vaccine for children he said it would herald a significant change in child mortality He added that though the vaccine is still expensive it will be included in routine immunisation to prevent children from dying from malaria once they become available We are also coming up with malaria that will be a significant change in the way that the child mortality is looked at The vaccine is still expensive That new vaccine is starting to be developed and once that becomes available for children it will change the dynamic and it s how you include that in the routine immunisation to prevent children from dying from malaria NAN reports that the 2021 World Malaria Report WMR 2021 indicates that Nigeria contributes 27 per cent of the global malaria cases and 32 per cent of global malaria deaths In 2021 the World Health Organisation WHO announced its recommendation of widespread use of the RTS 01 RTS S malaria vaccine among children in sub Saharan Africa and in other regions with moderate to high P falciparum malaria transmission The recommendation was based on results from a pilot programme in Ghana Kenya and Malawi that reached more than 900 000 children since 2019 Though the malaria vaccine is still under review the global target of the World Health Organisation is to reduce the incidence of the disease by at least 30 per cent by 2030 NewsSourceCredit NAN
    Improvement on immunisation in Nigeria fantastic — UNICEF 
    General news3 months ago

    Improvement on immunisation in Nigeria fantastic — UNICEF 

    Mr Peter Hawkins, the Country Representative, UN Children’s Fund (UNICEF) in Nigeria, says the improvement recorded in the number of children immunised against diseases in the country is fantastic.

    He gave the commendation on Sunday during the News Agency of Nigeria Forum in Abuja.

    NAN reports that the National Immunisation Coverage Survey (NICS) 2021 revealed that 57 per cent of Nigerian children received all three doses of pentavalent vaccines.

    Hawkins said that in spite of the COVID-19 pandemic, Nigeria was able to record an improvement in immunisation indices even when some other countries witnessed a drop.

    He added that “the situation in Nigeria, it’s not so much where we are today, it’s where we have come from.

    “In 2016, it was 34 per cent Penta three, so three, Penta vaccines for a child.

    “Now it is at 57 per cent, so that improvement is fantastic.

    Over the past three to four years, it increased from 50 per cent to 57 per cent.

    “So, that increase is fantastic, in actual fact, given that in the middle, we had COVID and in most countries, immunisation dropped.

    “In Nigeria, we put a lot of efforts, the National Primary Health Care Development Agency (NPHCDA) puts a lot of effort in maintaining importation of vaccines for routine immunisation, maintaining the structures so that they  continue to provide vaccination to children and 50 to 57 per cent is a fantastic achievement.

    ”Hawkins, however, said that though there was measurable improvement, 57 per cent is still insufficient for a country like Nigeria, and that the indicators around child mortality demonstrates that.

    According to him, the problem is in the fact that some states are performing at a high level, while some only record little improvement.

    He added that “Lagos State is at 82 per cent, if I remember correctly, and they have sustained it at that level, whereas a state like Sokoto has gone from seven per cent to 11 per cent.

    “Eleven per cent is the problem there.

    So it’s looking at the states where immunisation is low, seeing what the fundamental problems of why and then unbottling those bottlenecks to ensure that they go up to the 57 per cent, 60 per cent and ultimately get to 80 per cent.

    ”He also said that there are communities with zero dose children, adding that there are some communities even in Lagos State where immunisation has not reached.

    He explained that the NPHCDA, together with Global Alliance for Vaccine Immunisation (GAVI) and UNICEF have been working hard to ensure that those communities are not left behind.

    He also said that continuous financing for vaccines should be enabled to ensure that the gap is closed.

    For malaria vaccine for children, he said it would herald a significant change in child mortality.

    He added that though the vaccine is still expensive, it will be included in routine immunisation to prevent children from dying from malaria once they become available.

    “We are also coming up with malaria, that will be a significant change in the way that the child mortality is looked at.

    “The vaccine is still expensive.

    That new vaccine is starting to be developed and once that becomes available for children, it will change the dynamic and it’s how you include that in the routine immunisation to prevent children from dying from malaria.

    ”NAN reports that the 2021 World Malaria Report (WMR 2021) indicates that Nigeria contributes 27 per cent of the global malaria cases and 32 per cent of global malaria deaths.

    In 2021, the World Health Organisation (WHO) announced its recommendation of widespread use of the RTS,01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P.

    falciparum malaria transmission.

    The recommendation was based on results from a pilot programme in Ghana, Kenya and Malawi that reached more than 900,000 children since 2019.Though the malaria vaccine is still under review, the global target of the World Health Organisation is to reduce the incidence of the disease by at least 30 per cent by 2030.
    NewsSourceCredit: NAN

  •   Pharmaceutical company GSK has been awarded a contract to produce the world s first malaria vaccine so that millions more children are protected against the deadly disease the United Nations Children s Fund UNICEF announced on Tuesday The landmark award valued at up to 170 million will result in 18 million doses of the RTS S vaccine being made available over the next three years potentially saving the lives of thousands of young people each year Malaria remains one of the leading causes of death for children under the age of five In 2020 almost half a million children died from the disease in Africa alone at a rate of one death per minute Etleva Kadilli UNICEF Supply Division Director said the launch sends a clear message to malaria vaccine developers to continue their work We hope this is just the beginning Continued innovation is needed to develop new and next generation vaccines to increase the available supply and enable a healthier vaccine market she said This is a major step forward in our collective efforts to save children s lives and reduce the burden of malaria as part of broader malaria prevention and control programs Preventable disease Malaria is caused by parasites and is transmitted to humans through infected female Anopheles mosquitoes While the disease is preventable and curable it can be fatal if left untreated More than 30 countries have areas with moderate to high malaria transmission according to data from the World Health Organization WHOOpens in a new window and the vaccine could provide additional protection to more than 25 million children each year a once the supply increases The RTS S malaria vaccine the result of 35 years of research and development is the first vaccine against a parasitic disease Pilot program It was launched in a 2019 pilot program coordinated by the WHO in three countries Ghana Kenya and Malawi which has reached more than 800 000 children Last October the UN health agency recommended Opens in new window for widespread use in countries with moderate to high malaria transmission That December Gavi the Vaccine Alliance made the decision to provide funding for malaria vaccine programs in eligible countries thus paving the way for broader implementation of the vaccine Funding window opened CEO Seth Barkley reported that Gavi recently opened the application window for funding requests Thanks to UNICEF s procurement work we now have more certainty about supply and can go one step further in getting this life saving vaccine to the people who need it most As manufacturing increases over time we expect that increased volumes will also lead to lower and more sustainable prices he said Meanwhile the WHO has welcomed progress in ensuring timely supply and access to the vaccine so that more countries can introduce it as soon as possible Lives are at stake every day said Dr Kate O Brien director of WHO s Department of Immunization Vaccines and Biologicals Given the limited initial supply it is crucial that children who live in areas where disease risk and need are highest are prioritized first High demand expected UNICEF expects demand for the malaria vaccine to be high among affected countries As with any new vaccine supply will be limited at first the agency said but will increase as manufacturing capacity increases over time which in turn will lead to lower costs per dose Plans are already underway to boost production including through technology transfer UNICEF added so that every child at risk will one day have a chance to be immunized against this deadly disease
    Millions more children to benefit from world’s first malaria vaccine: United Nations Children’s International Emergency Fund (UNICEF)
      Pharmaceutical company GSK has been awarded a contract to produce the world s first malaria vaccine so that millions more children are protected against the deadly disease the United Nations Children s Fund UNICEF announced on Tuesday The landmark award valued at up to 170 million will result in 18 million doses of the RTS S vaccine being made available over the next three years potentially saving the lives of thousands of young people each year Malaria remains one of the leading causes of death for children under the age of five In 2020 almost half a million children died from the disease in Africa alone at a rate of one death per minute Etleva Kadilli UNICEF Supply Division Director said the launch sends a clear message to malaria vaccine developers to continue their work We hope this is just the beginning Continued innovation is needed to develop new and next generation vaccines to increase the available supply and enable a healthier vaccine market she said This is a major step forward in our collective efforts to save children s lives and reduce the burden of malaria as part of broader malaria prevention and control programs Preventable disease Malaria is caused by parasites and is transmitted to humans through infected female Anopheles mosquitoes While the disease is preventable and curable it can be fatal if left untreated More than 30 countries have areas with moderate to high malaria transmission according to data from the World Health Organization WHOOpens in a new window and the vaccine could provide additional protection to more than 25 million children each year a once the supply increases The RTS S malaria vaccine the result of 35 years of research and development is the first vaccine against a parasitic disease Pilot program It was launched in a 2019 pilot program coordinated by the WHO in three countries Ghana Kenya and Malawi which has reached more than 800 000 children Last October the UN health agency recommended Opens in new window for widespread use in countries with moderate to high malaria transmission That December Gavi the Vaccine Alliance made the decision to provide funding for malaria vaccine programs in eligible countries thus paving the way for broader implementation of the vaccine Funding window opened CEO Seth Barkley reported that Gavi recently opened the application window for funding requests Thanks to UNICEF s procurement work we now have more certainty about supply and can go one step further in getting this life saving vaccine to the people who need it most As manufacturing increases over time we expect that increased volumes will also lead to lower and more sustainable prices he said Meanwhile the WHO has welcomed progress in ensuring timely supply and access to the vaccine so that more countries can introduce it as soon as possible Lives are at stake every day said Dr Kate O Brien director of WHO s Department of Immunization Vaccines and Biologicals Given the limited initial supply it is crucial that children who live in areas where disease risk and need are highest are prioritized first High demand expected UNICEF expects demand for the malaria vaccine to be high among affected countries As with any new vaccine supply will be limited at first the agency said but will increase as manufacturing capacity increases over time which in turn will lead to lower costs per dose Plans are already underway to boost production including through technology transfer UNICEF added so that every child at risk will one day have a chance to be immunized against this deadly disease
    Millions more children to benefit from world’s first malaria vaccine: United Nations Children’s International Emergency Fund (UNICEF)
    Africa4 months ago

    Millions more children to benefit from world’s first malaria vaccine: United Nations Children’s International Emergency Fund (UNICEF)

    Pharmaceutical company GSK has been awarded a contract to produce the world's first malaria vaccine so that millions more children are protected against the deadly disease, the United Nations Children's Fund (UNICEF) announced on Tuesday.

    The landmark award, valued at up to $170 million, will result in 18 million doses of the RTS,S vaccine being made available over the next three years, potentially saving the lives of thousands of young people each year.

    Malaria remains one of the leading causes of death for children under the age of five.

    In 2020, almost half a million children died from the disease in Africa alone, at a rate of one death per minute.

    Etleva Kadilli, UNICEF Supply Division Director, said the launch sends a clear message to malaria vaccine developers to continue their work.

    “We hope this is just the beginning.

    Continued innovation is needed to develop new and next-generation vaccines to increase the available supply and enable a healthier vaccine market,” she said.

    "This is a major step forward in our collective efforts to save children's lives and reduce the burden of malaria as part of broader malaria prevention and control programs."

    Preventable disease Malaria is caused by parasites and is transmitted to humans through infected female Anopheles mosquitoes.

    While the disease is preventable and curable, it can be fatal if left untreated.

    More than 30 countries have areas with moderate to high malaria transmission, according to data from the World Health Organization (WHOOpens in a new window), and the vaccine could provide additional protection to more than 25 million children each year a once the supply increases.

    The RTS,S malaria vaccine, the result of 35 years of research and development, is the first vaccine against a parasitic disease.

    Pilot program It was launched in a 2019 pilot program, coordinated by the WHO, in three countries - Ghana, Kenya and Malawi - which has reached more than 800,000 children.

    Last October, the UN health agency recommended Opens in new window for widespread use in countries with moderate to high malaria transmission.

    That December, Gavi, the Vaccine Alliance, made the decision to provide funding for malaria vaccine programs in eligible countries, thus paving the way for broader implementation of the vaccine.

    Funding 'window' opened CEO Seth Barkley reported that Gavi recently opened the 'application window' for funding requests.

    “Thanks to UNICEF's procurement work, we now have more certainty about supply and can go one step further in getting this life-saving vaccine to the people who need it most.

    As manufacturing increases over time, we expect that increased volumes will also lead to lower and more sustainable prices,” he said.

    Meanwhile, the WHO has welcomed progress in ensuring timely supply and access to the vaccine so that more countries can introduce it as soon as possible.

    “Lives are at stake every day,” said Dr. Kate O'Brien, director of WHO's Department of Immunization, Vaccines and Biologicals.

    “Given the limited initial supply, it is crucial that children who live in areas where disease risk and need are highest are prioritized first.” High demand expected UNICEF expects demand for the malaria vaccine to be high among affected countries.

    As with any new vaccine, supply will be limited at first, the agency said, but will increase as manufacturing capacity increases over time, which in turn will lead to lower costs per dose.

    Plans are already underway to boost production, including through technology transfer, UNICEF added, "so that every child at risk will one day have a chance to be immunized against this deadly disease."

  •   UNICEF awards 170m malaria vaccine contracUnited Nations Children s Fund UNICEF has awarded a contract for the first ever supply of a malaria vaccine to GSK with a value of up to 170 million dollars The News Agency of Nigeria reports that GSK plc formerly GlaxoSmithKline plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London England Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham UNICEF in a statement issued from New York on Tuesday said the landmark award would lead to 18 million doses of RTS 01 RTS S being available over the next three years potentially saving thousands of lives every year In 2020 nearly half a million children died from malaria in Africa alone a rate of one child death per minute Etleva Kadilli Director of UNICEF s Supply Division said the vaccine rollout would give a clear message to malaria vaccine developers to continue their work because malaria vaccines are needed and wanted We hope this is just the beginning Continued innovation is needed to develop new and next generation vaccines to increase available supply and enable a healthier vaccine market This is a giant step forward in our collective efforts to save children s lives and reduce the burden of malaria as part of wider malaria prevention and control programmes According to WHO data more than 30 countries have areas with moderate to high malaria transmission where the vaccine could provide added protection against malaria to over 25 million children each year once supply scales up The RTS S malaria vaccine is the result of 35 years of research and development and is the first ever vaccine against a parasitic disease The vaccine acts against Plasmodium falciparum the most deadly malaria parasite globally and the most prevalent in Africa In 2019 pilot routine vaccine use was launched in three countries Ghana Kenya and Malawi as part of the Malaria Vaccine Implementation Programme coordinated by WHO The experience and evidence generated by the pilots informed WHO s recommendation in October 2021 for widespread use of the first malaria vaccine in countries with moderate to high P falciparum malaria transmission Soon after in December 2021 Gavi the Vaccine Alliance s decision to provide funding for malaria vaccine programmes in eligible countries opened the pathway for broader roll out of the vaccine We recently opened the first application window for Gavi support in rolling out the malaria vaccine Thanks to UNICEF s procurement work we now have more certainty on supply and can move a step further towards getting this life saving vaccine to the people who need it the most As manufacturing ramps up over time we hope that increasing volumes will also lead to more sustainable lower prices Seth Berkley CEO of Gavi the Vaccine Alliance said Dr Kate O Brien WHO Director of the Department of Immunisation Vaccines and Biologicals said lives are at stake every day WHO welcomes the progress to secure supply and timely access to vaccine so that more countries can begin to introduce this additional malaria prevention tool as rapidly as possible Given the initial limited supply it is crucial that children living in areas where the risk of disease and need is highest are prioritised first This award is the culmination of 18 months of intensive preparation and consultation with industry and partners As the largest buyer of vaccines in the world UNICEF accelerated action to conclude procurement negotiations to ensure there are no delays in securing available supplies of the malaria vaccine to help protect vulnerable children Demand for the malaria vaccine is expected to be high among affected countries As with any new vaccine supply will be limited at first and will increase over time as manufacturing capacity ramps up to the level required As volumes increase costs per dose should decrease Plans are already underway to boost production including through technology transfer so that every child at risk will one day have the opportunity to be immunized against this killer disease We must not lose sight of the need to accelerate access to this and future malaria vaccines and to make the necessary investments in malaria control and immunization services as well as in research and development Effective malaria and immunization programs are both key to the successful delivery of a malaria vaccine and contribute to stronger health systems overall Dr Ashley Birkett Global Head of Malaria Vaccines and Biologics at PATH said UNICEF supports the regional diversification of vaccine production and encourages GSK and other pipeline manufacturers to consider partnering with companies in Africa as part of this effort www nannews ng NewsSourceCredit NAN
    UNICEF awards 0m malaria vaccine contract to GSK
      UNICEF awards 170m malaria vaccine contracUnited Nations Children s Fund UNICEF has awarded a contract for the first ever supply of a malaria vaccine to GSK with a value of up to 170 million dollars The News Agency of Nigeria reports that GSK plc formerly GlaxoSmithKline plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London England Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham UNICEF in a statement issued from New York on Tuesday said the landmark award would lead to 18 million doses of RTS 01 RTS S being available over the next three years potentially saving thousands of lives every year In 2020 nearly half a million children died from malaria in Africa alone a rate of one child death per minute Etleva Kadilli Director of UNICEF s Supply Division said the vaccine rollout would give a clear message to malaria vaccine developers to continue their work because malaria vaccines are needed and wanted We hope this is just the beginning Continued innovation is needed to develop new and next generation vaccines to increase available supply and enable a healthier vaccine market This is a giant step forward in our collective efforts to save children s lives and reduce the burden of malaria as part of wider malaria prevention and control programmes According to WHO data more than 30 countries have areas with moderate to high malaria transmission where the vaccine could provide added protection against malaria to over 25 million children each year once supply scales up The RTS S malaria vaccine is the result of 35 years of research and development and is the first ever vaccine against a parasitic disease The vaccine acts against Plasmodium falciparum the most deadly malaria parasite globally and the most prevalent in Africa In 2019 pilot routine vaccine use was launched in three countries Ghana Kenya and Malawi as part of the Malaria Vaccine Implementation Programme coordinated by WHO The experience and evidence generated by the pilots informed WHO s recommendation in October 2021 for widespread use of the first malaria vaccine in countries with moderate to high P falciparum malaria transmission Soon after in December 2021 Gavi the Vaccine Alliance s decision to provide funding for malaria vaccine programmes in eligible countries opened the pathway for broader roll out of the vaccine We recently opened the first application window for Gavi support in rolling out the malaria vaccine Thanks to UNICEF s procurement work we now have more certainty on supply and can move a step further towards getting this life saving vaccine to the people who need it the most As manufacturing ramps up over time we hope that increasing volumes will also lead to more sustainable lower prices Seth Berkley CEO of Gavi the Vaccine Alliance said Dr Kate O Brien WHO Director of the Department of Immunisation Vaccines and Biologicals said lives are at stake every day WHO welcomes the progress to secure supply and timely access to vaccine so that more countries can begin to introduce this additional malaria prevention tool as rapidly as possible Given the initial limited supply it is crucial that children living in areas where the risk of disease and need is highest are prioritised first This award is the culmination of 18 months of intensive preparation and consultation with industry and partners As the largest buyer of vaccines in the world UNICEF accelerated action to conclude procurement negotiations to ensure there are no delays in securing available supplies of the malaria vaccine to help protect vulnerable children Demand for the malaria vaccine is expected to be high among affected countries As with any new vaccine supply will be limited at first and will increase over time as manufacturing capacity ramps up to the level required As volumes increase costs per dose should decrease Plans are already underway to boost production including through technology transfer so that every child at risk will one day have the opportunity to be immunized against this killer disease We must not lose sight of the need to accelerate access to this and future malaria vaccines and to make the necessary investments in malaria control and immunization services as well as in research and development Effective malaria and immunization programs are both key to the successful delivery of a malaria vaccine and contribute to stronger health systems overall Dr Ashley Birkett Global Head of Malaria Vaccines and Biologics at PATH said UNICEF supports the regional diversification of vaccine production and encourages GSK and other pipeline manufacturers to consider partnering with companies in Africa as part of this effort www nannews ng NewsSourceCredit NAN
    UNICEF awards 0m malaria vaccine contract to GSK
    Foreign4 months ago

    UNICEF awards $170m malaria vaccine contract to GSK

    UNICEF awards $170m malaria vaccine contracUnited Nations Children’s Fund (UNICEF) has awarded a contract for the first ever supply of a malaria vaccine to GSK with a value of up to 170 million dollars.

    The News Agency of Nigeria reports that GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England.

    Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.

    UNICEF in a statement issued from New York on Tuesday said the landmark award would lead to 18 million doses of RTS,01 (RTS,S) being available over the next three years, potentially saving thousands of lives every year.

    In 2020, nearly half a million children died from malaria in Africa alone, a rate of one child death per minute.

    Etleva Kadilli, Director of UNICEF’s Supply Division said the vaccine rollout would give a clear message to malaria vaccine developers to continue their work because malaria vaccines are needed and wanted.

    “We hope this is just the beginning.

    Continued innovation is needed to develop new and next-generation vaccines to increase available supply, and enable a healthier vaccine market.

    “This is a giant step forward in our collective efforts to save children’s lives and reduce the burden of malaria as part of wider malaria prevention and control programmes.

    ” According to WHO data, more than 30 countries have areas with moderate to high malaria transmission, where the vaccine could provide added protection against malaria to over 25 million children each year once supply scales up.

    The RTS,S malaria vaccine is the result of 35 years of research and development and is the first-ever vaccine against a parasitic disease.

    The vaccine acts against Plasmodium falciparum, the most deadly malaria parasite globally and the most prevalent in Africa.

    In 2019, pilot routine vaccine use was launched in three countries – Ghana, Kenya and Malawi – as part of the Malaria Vaccine Implementation Programme coordinated by WHO.

    The experience and evidence generated by the pilots informed WHO’s recommendation in October 2021 for widespread use of the first malaria vaccine in countries with moderate to high P.

    falciparum malaria transmission.

    Soon after, in December 2021, Gavi, the Vaccine Alliance’s decision to provide funding for malaria vaccine programmes in eligible countries opened the pathway for broader roll-out of the vaccine.

    “We recently opened the first application window for Gavi support in rolling out the malaria vaccine.

    “Thanks to UNICEF’s procurement work, we now have more certainty on supply and can move a step further towards getting this life-saving vaccine to the people who need it the most.

    “As manufacturing ramps up over time, we hope that increasing volumes will also lead to more sustainable, lower prices,” Seth Berkley, CEO of Gavi, the Vaccine Alliance, said.

    Dr Kate O’Brien, WHO Director of the Department of Immunisation, Vaccines and Biologicals said lives are at stake, every day.

    “WHO welcomes the progress to secure supply and timely access to vaccine so that more countries can begin to introduce this additional malaria prevention tool as rapidly as possible.

    “Given the initial limited supply, it is crucial that children living in areas where the risk of disease and need is highest are prioritised first.

    ” This award is the culmination of 18 months of intensive preparation and consultation with industry and partners.

    As the largest buyer of vaccines in the world, UNICEF accelerated action to conclude procurement negotiations, to ensure there are no delays in securing available supplies of the malaria vaccine to help protect vulnerable children.

    Demand for the malaria vaccine is expected to be high among affected countries.

    As with any new vaccine, supply will be limited at first and will increase over time as manufacturing capacity ramps up to the level required.

    As volumes increase, costs per dose should decrease.

    Plans are already underway to boost production, including through technology transfer, so that every child at risk will one day have the opportunity to be immunized against this killer disease.

    “We must not lose sight of the need to accelerate access to this and future malaria vaccines, and to make the necessary investments in malaria control and immunization services, as well as in research and development.

    “Effective malaria and immunization programs are both key to the successful delivery of a malaria vaccine and contribute to stronger health systems overall,” Dr Ashley Birkett, Global Head of Malaria Vaccines and Biologics at PATH, said.

    UNICEF supports the regional diversification of vaccine production and encourages GSK and other pipeline manufacturers to consider partnering with companies in Africa as part of this effort.

    (www.

    nannews.

    ng)
    NewsSourceCredit: NAN

  •   The World Health Organization WHO welcomes the launch by Gavi the Vaccine Alliance of the historic opportunity for countries to apply for funding to introduce or further deploy the RTS S AS01 malaria vaccine RTS S This international support of almost US 160 million between 2022 and 2025 will facilitate increased access to the vaccine for children at high risk of illness and death from malaria starting with Ghana Kenya and Malawi the three African countries that began the pilot introduction of the vaccine in 2019 and then expand to other eligible endemic countries Malaria remains one of the leading causes of childhood illness and death in sub Saharan Africa In 2020 almost half a million African children died of malaria or 1 child died of malaria every minute Since the world s first malaria vaccine was introduced in 2019 it has been well accepted in African communities after a relatively short period of time Demand is high even in the context of COVID 19 vaccination yields for the first dose are reaching between 73 and more than 90 coverage depending on the country without major interruptions during the pandemic To date around 1 3 million children have benefited from the vaccine in the three African pilot countries Gavi s new funding opportunity brings us one step closer to reaching millions more children in Africa with the life saving RTS S malaria vaccine said Dr Matshidiso Moeti WHO Regional Director for Africa Throughout the pandemic when routine health services faced myriad challenges parents and caregivers diligently brought their children to clinics and health posts to be vaccinated against malaria They know very well that malaria takes lives every day and they are eager to protect their children from this deadly disease Following the WHO recommendation in October 2021 for widespread use of the RTS S malaria vaccine among children in regions with moderate to high transmission of Plasmodium falciparum malaria several malaria endemic countries have expressed interest in adopting the vaccine vaccine and are expected to request Gavi support for the introduction of the vaccine The RTS S vaccine works specifically against Plasmodium falciparum which is the deadliest malaria parasite and the most prevalent on the African continent Where the vaccine has been introduced there has been a substantial decrease in children hospitalized with severe malaria and a decrease in deaths among children in the age group eligible for the vaccine Gavi has indicated that the first application deadline in September 2022 is reserved for countries that are currently testing the vaccine and for which the continuity of the vaccine program is a priority A second window open to other eligible malaria endemic countries will close in January 2023 Countries can already submit expressions of interest during the first funding window for inclusion in this round Malaria has devastated communities for too long in Africa We know that initially the supply will not meet the demand however we look forward to working with countries and our partners to introduce and scale this new tool in our fight against malaria which could save the lives of thousands of children across the continent said Thabani Maphosa Director General of Country Programs at Gavi Gavi is proud to support this vaccine and we hope this is just the beginning of a broader rollout that will see populations across the continent increasingly protected against this deadly disease As with many new vaccines malaria vaccine supply is limited as vaccine production ramps up The long awaited malaria vaccine for children is a breakthrough for science child health and malaria control It is projected that at scale the use of this vaccine could save tens of thousands of young lives each year but we will need a larger supply of the vaccine if Africa is to reap the benefits of this additional tool for malaria prevention Professor Rose said Leke a malaria expert at the University of Yaound in Cameroon and co chair of the expert group that advised the WHO on a framework for allocating the currently limited supply of malaria vaccines In the coming years the supply of the RTS S malaria vaccine will be insufficient to meet the needs of the more than 25 million children born each year in areas where the vaccine is recommended according to a global market study commissioned by the WHO If a second malaria vaccine successfully completes clinical development and is approved for use the limited supply period could be shorter It is estimated that the demand ranges between 80 and 100 million doses per year In response to the supply situation WHO has developed with expert advice a framework to guide vaccine allocation decisions at the global and national levels that ensures that children most at risk in endemic countries are prioritized to receive the vaccine The framework also aims to ensure that childhood immunization services started in the three pilot countries continue without interruption until supply fully meets demand Now is the time for African countries and communities to express their interest to donors health leaders and manufacturers in early access to this vaccine Lives are at stake every day added Dr Moeti This situation once again underlines why expanded local production of vaccines is essential to meet health needs in Africa We have seen encouraging first steps in that direction in recent months and we are committed to supporting further efforts to expand vaccine production in Africa WHO Gavi and their partners are working to accelerate the supply of RTS S by exploring approaches to increase manufacturing capacity shape the market and facilitate the development of other first and next generation malaria vaccines Dr Moeti spoke during a virtual press conference today She was joined by Mr Maphosa and Professor Leke Also available from the WHO Regional Office for Africa to answer questions Dr Akpaka Kalu Team Leader Strategic Policy and Planning Communicable and Noncommunicable Diseases Group Dr Opeayo Ogundiran Pillar Leader of epidemiology for the regional response to COVID 19 Dr Phionah Atuhebwe Medical Officer New Vaccines and Dr Solomon Woldetsadik Emergency Response Officer
    Historic funding to scale-up launch of Africa’s first malaria vaccine
      The World Health Organization WHO welcomes the launch by Gavi the Vaccine Alliance of the historic opportunity for countries to apply for funding to introduce or further deploy the RTS S AS01 malaria vaccine RTS S This international support of almost US 160 million between 2022 and 2025 will facilitate increased access to the vaccine for children at high risk of illness and death from malaria starting with Ghana Kenya and Malawi the three African countries that began the pilot introduction of the vaccine in 2019 and then expand to other eligible endemic countries Malaria remains one of the leading causes of childhood illness and death in sub Saharan Africa In 2020 almost half a million African children died of malaria or 1 child died of malaria every minute Since the world s first malaria vaccine was introduced in 2019 it has been well accepted in African communities after a relatively short period of time Demand is high even in the context of COVID 19 vaccination yields for the first dose are reaching between 73 and more than 90 coverage depending on the country without major interruptions during the pandemic To date around 1 3 million children have benefited from the vaccine in the three African pilot countries Gavi s new funding opportunity brings us one step closer to reaching millions more children in Africa with the life saving RTS S malaria vaccine said Dr Matshidiso Moeti WHO Regional Director for Africa Throughout the pandemic when routine health services faced myriad challenges parents and caregivers diligently brought their children to clinics and health posts to be vaccinated against malaria They know very well that malaria takes lives every day and they are eager to protect their children from this deadly disease Following the WHO recommendation in October 2021 for widespread use of the RTS S malaria vaccine among children in regions with moderate to high transmission of Plasmodium falciparum malaria several malaria endemic countries have expressed interest in adopting the vaccine vaccine and are expected to request Gavi support for the introduction of the vaccine The RTS S vaccine works specifically against Plasmodium falciparum which is the deadliest malaria parasite and the most prevalent on the African continent Where the vaccine has been introduced there has been a substantial decrease in children hospitalized with severe malaria and a decrease in deaths among children in the age group eligible for the vaccine Gavi has indicated that the first application deadline in September 2022 is reserved for countries that are currently testing the vaccine and for which the continuity of the vaccine program is a priority A second window open to other eligible malaria endemic countries will close in January 2023 Countries can already submit expressions of interest during the first funding window for inclusion in this round Malaria has devastated communities for too long in Africa We know that initially the supply will not meet the demand however we look forward to working with countries and our partners to introduce and scale this new tool in our fight against malaria which could save the lives of thousands of children across the continent said Thabani Maphosa Director General of Country Programs at Gavi Gavi is proud to support this vaccine and we hope this is just the beginning of a broader rollout that will see populations across the continent increasingly protected against this deadly disease As with many new vaccines malaria vaccine supply is limited as vaccine production ramps up The long awaited malaria vaccine for children is a breakthrough for science child health and malaria control It is projected that at scale the use of this vaccine could save tens of thousands of young lives each year but we will need a larger supply of the vaccine if Africa is to reap the benefits of this additional tool for malaria prevention Professor Rose said Leke a malaria expert at the University of Yaound in Cameroon and co chair of the expert group that advised the WHO on a framework for allocating the currently limited supply of malaria vaccines In the coming years the supply of the RTS S malaria vaccine will be insufficient to meet the needs of the more than 25 million children born each year in areas where the vaccine is recommended according to a global market study commissioned by the WHO If a second malaria vaccine successfully completes clinical development and is approved for use the limited supply period could be shorter It is estimated that the demand ranges between 80 and 100 million doses per year In response to the supply situation WHO has developed with expert advice a framework to guide vaccine allocation decisions at the global and national levels that ensures that children most at risk in endemic countries are prioritized to receive the vaccine The framework also aims to ensure that childhood immunization services started in the three pilot countries continue without interruption until supply fully meets demand Now is the time for African countries and communities to express their interest to donors health leaders and manufacturers in early access to this vaccine Lives are at stake every day added Dr Moeti This situation once again underlines why expanded local production of vaccines is essential to meet health needs in Africa We have seen encouraging first steps in that direction in recent months and we are committed to supporting further efforts to expand vaccine production in Africa WHO Gavi and their partners are working to accelerate the supply of RTS S by exploring approaches to increase manufacturing capacity shape the market and facilitate the development of other first and next generation malaria vaccines Dr Moeti spoke during a virtual press conference today She was joined by Mr Maphosa and Professor Leke Also available from the WHO Regional Office for Africa to answer questions Dr Akpaka Kalu Team Leader Strategic Policy and Planning Communicable and Noncommunicable Diseases Group Dr Opeayo Ogundiran Pillar Leader of epidemiology for the regional response to COVID 19 Dr Phionah Atuhebwe Medical Officer New Vaccines and Dr Solomon Woldetsadik Emergency Response Officer
    Historic funding to scale-up launch of Africa’s first malaria vaccine
    Africa4 months ago

    Historic funding to scale-up launch of Africa’s first malaria vaccine

    The World Health Organization (WHO) welcomes the launch by Gavi, the Vaccine Alliance, of the historic opportunity for countries to apply for funding to introduce or further deploy the RTS,S/AS01 malaria vaccine ( RTS, S). This international support of almost US$160 million between 2022 and 2025 will facilitate increased access to the vaccine for children at high risk of illness and death from malaria, starting with Ghana, Kenya and Malawi, the three African countries that began the pilot introduction of the vaccine in 2019, and then expand to other eligible endemic countries.

    Malaria remains one of the leading causes of childhood illness and death in sub-Saharan Africa. In 2020, almost half a million African children died of malaria, or 1 child died of malaria every minute.

    Since the world's first malaria vaccine was introduced in 2019, it has been well accepted in African communities after a relatively short period of time. Demand is high even in the context of COVID-19: vaccination yields for the first dose are reaching between 73% and more than 90% coverage, depending on the country, without major interruptions during the pandemic. To date, around 1.3 million children have benefited from the vaccine in the three African pilot countries.

    "Gavi's new funding opportunity brings us one step closer to reaching millions more children in Africa with the life-saving RTS,S malaria vaccine," said Dr Matshidiso Moeti, WHO Regional Director for Africa. . “Throughout the pandemic, when routine health services faced myriad challenges, parents and caregivers diligently brought their children to clinics and health posts to be vaccinated against malaria. They know very well that malaria takes lives every day and they are eager to protect their children from this deadly disease.”

    Following the WHO recommendation in October 2021 for widespread use of the RTS,S malaria vaccine among children in regions with moderate to high transmission of Plasmodium falciparum malaria, several malaria-endemic countries have expressed interest in adopting the vaccine. vaccine and are expected to request Gavi support for the introduction of the vaccine. The RTS,S vaccine works specifically against Plasmodium falciparum, which is the deadliest malaria parasite and the most prevalent on the African continent. Where the vaccine has been introduced, there has been a substantial decrease in children hospitalized with severe malaria and a decrease in deaths among children in the age group eligible for the vaccine.

    Gavi has indicated that the first application deadline in September 2022 is reserved for countries that are currently testing the vaccine and for which the continuity of the vaccine program is a priority. A second window open to other eligible malaria-endemic countries will close in January 2023. Countries can already submit expressions of interest during the first funding window for inclusion in this round.

    “Malaria has devastated communities for too long in Africa. We know that initially, the supply will not meet the demand, however, we look forward to working with countries and our partners to introduce and scale this new tool in our fight against malaria, which could save the lives of thousands of children across the continent” . said Thabani Maphosa, Director General of Country Programs at Gavi. "Gavi is proud to support this vaccine, and we hope this is just the beginning of a broader rollout that will see populations across the continent increasingly protected against this deadly disease."

    As with many new vaccines, malaria vaccine supply is limited as vaccine production ramps up.

    “The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control. It is projected that, at scale, the use of this vaccine could save tens of thousands of young lives each year, but we will need a larger supply of the vaccine if Africa is to reap the benefits of this additional tool for malaria prevention." Professor Rose said. Leke, a malaria expert at the University of Yaoundé in Cameroon, and co-chair of the expert group that advised the WHO on a framework for allocating the currently limited supply of malaria vaccines.

    In the coming years, the supply of the RTS,S malaria vaccine will be insufficient to meet the needs of the more than 25 million children born each year in areas where the vaccine is recommended, according to a global market study commissioned by the WHO. If a second malaria vaccine successfully completes clinical development and is approved for use, the limited supply period could be shorter. It is estimated that the demand ranges between 80 and 100 million doses per year.

    In response to the supply situation, WHO has developed, with expert advice, a framework to guide vaccine allocation decisions at the global and national levels that ensures that children most at risk in endemic countries are prioritized to receive the vaccine. The framework also aims to ensure that childhood immunization services started in the three pilot countries continue without interruption, until supply fully meets demand.

    “Now is the time for African countries and communities to express their interest, to donors, health leaders and manufacturers, in early access to this vaccine. Lives are at stake every day,” added Dr. Moeti. “This situation once again underlines why expanded local production of vaccines is essential to meet health needs in Africa. We have seen encouraging first steps in that direction in recent months, and we are committed to supporting further efforts to expand vaccine production in Africa."

    WHO, Gavi and their partners are working to accelerate the supply of RTS,S by exploring approaches to increase manufacturing capacity, shape the market and facilitate the development of other first and next generation malaria vaccines.

    Dr. Moeti spoke during a virtual press conference today. She was joined by Mr. Maphosa and Professor Leke.

    Also available from the WHO Regional Office for Africa to answer questions: Dr Akpaka Kalu, Team Leader, Strategic Policy and Planning, Communicable and Noncommunicable Diseases Group, Dr Opeayo Ogundiran, Pillar Leader of epidemiology for the regional response to COVID-19; Dr. Phionah Atuhebwe, Medical Officer, New Vaccines and Dr. Solomon Woldetsadik, Emergency Response Officer.

  •   One migrant was killed and at least six others including a teenage girl were injured in a shootout between groups of migrants in Serbia near the Hungarian border on Saturday state television RTS reported The 16 year old girl suffered life threatening injuries in the incident that occurred in a forest on the outskirts of Subotica about 160 kilometers 100 miles north of Belgrade where the injured were hospitalized RTS reported Police who did not immediately comment blocked access to the forest where the incident occurred just a kilometer from the Hungarian border Interior Minister Aleksandar Vulin rushed to the scene The injured aged between 20 and 30 have no documents Subotica Mayor Stevan Bakic told local media It is not known what triggered the incident he added Local media reported that the shooting occurred between Afghan and Pakistani immigrants likely due to people smuggling from the area to Hungary a member of the European Union Serbia is on the so called Balkan route used by immigrants heading to Western Europe as they flee war and poverty in the Middle East Asia and Africa Although the route is not as busy as it was during Europe s 2015 migration crisis tens of thousands of illegal immigrants still cross the region annually
    One killed, six injured in Serbia migrant shootout
      One migrant was killed and at least six others including a teenage girl were injured in a shootout between groups of migrants in Serbia near the Hungarian border on Saturday state television RTS reported The 16 year old girl suffered life threatening injuries in the incident that occurred in a forest on the outskirts of Subotica about 160 kilometers 100 miles north of Belgrade where the injured were hospitalized RTS reported Police who did not immediately comment blocked access to the forest where the incident occurred just a kilometer from the Hungarian border Interior Minister Aleksandar Vulin rushed to the scene The injured aged between 20 and 30 have no documents Subotica Mayor Stevan Bakic told local media It is not known what triggered the incident he added Local media reported that the shooting occurred between Afghan and Pakistani immigrants likely due to people smuggling from the area to Hungary a member of the European Union Serbia is on the so called Balkan route used by immigrants heading to Western Europe as they flee war and poverty in the Middle East Asia and Africa Although the route is not as busy as it was during Europe s 2015 migration crisis tens of thousands of illegal immigrants still cross the region annually
    One killed, six injured in Serbia migrant shootout
    Foreign5 months ago

    One killed, six injured in Serbia migrant shootout

    One migrant was killed and at least six others, including a teenage girl, were injured in a shootout between groups of migrants in Serbia near the Hungarian border on Saturday, state television RTS reported.

    The 16-year-old girl suffered life-threatening injuries in the incident that occurred in a forest on the outskirts of Subotica, about 160 kilometers (100 miles) north of Belgrade, where the injured were hospitalized, RTS reported.

    Police, who did not immediately comment, blocked access to the forest where the incident occurred, just a kilometer from the Hungarian border.

    Interior Minister Aleksandar Vulin rushed to the scene.

    The injured, aged between 20 and 30, have no documents, Subotica Mayor Stevan Bakic told local media.

    It is not known what triggered the incident, he added.

    Local media reported that the shooting occurred between Afghan and Pakistani immigrants, likely due to people smuggling from the area to Hungary, a member of the European Union.

    Serbia is on the so-called Balkan route used by immigrants heading to Western Europe as they flee war and poverty in the Middle East, Asia and Africa.

    Although the route is not as busy as it was during Europe's 2015 migration crisis, tens of thousands of illegal immigrants still cross the region annually.

  •   President Uhuru Kenyatta has praised the Kenya Defense Forces KDF for its commitment to serving beyond its primary mandate of defending the country against external aggression The president who was accompanied by first lady Margaret Kenyatta noted that as a modern and versatile military the KDF has taken on unknown nation building roles and excelled in them Because of its track record of delivering superlative results I have tasked the KDF from time to time with taking on various strategic national programs and even rescuing failing institutions They did it by reactivating nearly 600 kilometers of dead gauge in an impressive way ahead of schedule and on budget the president said President Kenyatta spoke Friday as he presided over the parade of KDF recruits at the Recruit Training School RTS in Eldoret where he congratulated graduates for completing a rigorous six month basic military training course The president also cited the revival of the Kenya Meat Commission into a for profit company in record time and the Kenya Shipyard which is poised to become the largest shipyard in sub Saharan Africa as some of the achievements of the KDF in supporting the country s development agenda Other KDF achievements include the construction of the Uhuru Gardens National Monument and Museum in just 22 months instead of 10 years as well as increasing access to basic health services for Nairobi residents by the Nairobi Metropolitan Services NMS You also did it for the nation when you anchored our national response to the Covid 19 pandemic and in times of national disasters and civil emergencies their efforts saved lives and property said President Kenyatta He appreciated the Chief of the Defense Forces General Robert Kibochi the Service Commanders and all officers serving in the senior ranks of the armed forces for their outstanding stewardship of the KDF Highlighting steps taken to modernize the KDF the president said the government has invested heavily in officer training providing state of the art equipment improving healthcare facilities accommodation pay and general terms and conditions of service for the armed forces Over the past nine years in recognition of the importance of peace and security to the realization of our development agenda we have undertaken the most significant and expansive modernization of our military in our nation s history the president said In addition President Kenyatta said that the government has enacted a law that creates guarantees for KDF officers in their retirement and also facilitates the integration of the disabled or seriously injured in the performance of their duties To seal this guarantee on June 15 of this year I had the rare honor and privilege of signing the Military Veterans Act into law he said Noting that the political pace towards the upcoming elections is reaching a fever pitch President Kenyatta urged all Kenyans to reflect on the sacrifice made by KDF officers in their service and in defense of Kenya by putting the interests of the country in everything they do Over the last 9 years some of the most harrowing decisions were the ones that would put our soldiers in harm s way These were difficult decisions because the officers are our children and when they go out on any mission in defense of our borders at home or abroad I knew very well that they would either return raising our national flag or return wrapped in our national flag said the President Present at the ceremony were Cabinet Secretary for Defense Eugene Wamalwa Chief of Defense Forces General Robert Kibochi Commander of the Kenya Army Lieutenant General Walter R Koipaton Commander of the Kenya Air Force Maj Gen John Omenda Kenyan Navy Commander Maj Gen Jimson Mutai and RTS Commander Brig Paul Njema Others were the Inspector General of Police Hillary Mutyambai Governor Jackson Mandago and his counterpart from Elgeyo Marakwet Alex Tolgos among others Earlier when he arrived at the Recruit Training School the Head of State officially opened the new state of the art Eldoret Regional Hospital which will serve the health needs of officers serving in the North Rift Western and Nyanza regions
    President Kenyatta Lauds Kenya Defence Forces (KDF) for Serving the Country Beyond the Call of Duty
      President Uhuru Kenyatta has praised the Kenya Defense Forces KDF for its commitment to serving beyond its primary mandate of defending the country against external aggression The president who was accompanied by first lady Margaret Kenyatta noted that as a modern and versatile military the KDF has taken on unknown nation building roles and excelled in them Because of its track record of delivering superlative results I have tasked the KDF from time to time with taking on various strategic national programs and even rescuing failing institutions They did it by reactivating nearly 600 kilometers of dead gauge in an impressive way ahead of schedule and on budget the president said President Kenyatta spoke Friday as he presided over the parade of KDF recruits at the Recruit Training School RTS in Eldoret where he congratulated graduates for completing a rigorous six month basic military training course The president also cited the revival of the Kenya Meat Commission into a for profit company in record time and the Kenya Shipyard which is poised to become the largest shipyard in sub Saharan Africa as some of the achievements of the KDF in supporting the country s development agenda Other KDF achievements include the construction of the Uhuru Gardens National Monument and Museum in just 22 months instead of 10 years as well as increasing access to basic health services for Nairobi residents by the Nairobi Metropolitan Services NMS You also did it for the nation when you anchored our national response to the Covid 19 pandemic and in times of national disasters and civil emergencies their efforts saved lives and property said President Kenyatta He appreciated the Chief of the Defense Forces General Robert Kibochi the Service Commanders and all officers serving in the senior ranks of the armed forces for their outstanding stewardship of the KDF Highlighting steps taken to modernize the KDF the president said the government has invested heavily in officer training providing state of the art equipment improving healthcare facilities accommodation pay and general terms and conditions of service for the armed forces Over the past nine years in recognition of the importance of peace and security to the realization of our development agenda we have undertaken the most significant and expansive modernization of our military in our nation s history the president said In addition President Kenyatta said that the government has enacted a law that creates guarantees for KDF officers in their retirement and also facilitates the integration of the disabled or seriously injured in the performance of their duties To seal this guarantee on June 15 of this year I had the rare honor and privilege of signing the Military Veterans Act into law he said Noting that the political pace towards the upcoming elections is reaching a fever pitch President Kenyatta urged all Kenyans to reflect on the sacrifice made by KDF officers in their service and in defense of Kenya by putting the interests of the country in everything they do Over the last 9 years some of the most harrowing decisions were the ones that would put our soldiers in harm s way These were difficult decisions because the officers are our children and when they go out on any mission in defense of our borders at home or abroad I knew very well that they would either return raising our national flag or return wrapped in our national flag said the President Present at the ceremony were Cabinet Secretary for Defense Eugene Wamalwa Chief of Defense Forces General Robert Kibochi Commander of the Kenya Army Lieutenant General Walter R Koipaton Commander of the Kenya Air Force Maj Gen John Omenda Kenyan Navy Commander Maj Gen Jimson Mutai and RTS Commander Brig Paul Njema Others were the Inspector General of Police Hillary Mutyambai Governor Jackson Mandago and his counterpart from Elgeyo Marakwet Alex Tolgos among others Earlier when he arrived at the Recruit Training School the Head of State officially opened the new state of the art Eldoret Regional Hospital which will serve the health needs of officers serving in the North Rift Western and Nyanza regions
    President Kenyatta Lauds Kenya Defence Forces (KDF) for Serving the Country Beyond the Call of Duty
    Africa5 months ago

    President Kenyatta Lauds Kenya Defence Forces (KDF) for Serving the Country Beyond the Call of Duty

    President Uhuru Kenyatta has praised the Kenya Defense Forces (KDF) for its commitment to serving beyond its primary mandate of defending the country against external aggression.

    The president, who was accompanied by first lady Margaret Kenyatta, noted that as a modern and versatile military, the KDF has taken on unknown nation-building roles and excelled in them.

    “Because of its track record of delivering superlative results, I have tasked the KDF from time to time with taking on various strategic national programs and even rescuing failing institutions.

    "They did it by reactivating nearly 600 kilometers of dead gauge in an impressive way, ahead of schedule and on budget," the president said.

    President Kenyatta spoke Friday as he presided over the parade of KDF recruits at the Recruit Training School (RTS) in Eldoret, where he congratulated graduates for completing a rigorous six-month basic military training course.

    The president also cited the revival of the Kenya Meat Commission into a for-profit company in record time and the Kenya Shipyard, which is poised to become the largest shipyard in sub-Saharan Africa, as some of the achievements of the KDF in supporting the country's development agenda. .

    Other KDF achievements include the construction of the Uhuru Gardens National Monument and Museum in just 22 months instead of 10 years, as well as increasing access to basic health services for Nairobi residents by the Nairobi Metropolitan Services (NMS). ).

    “You also did it for the nation when you anchored our national response to the Covid-19 pandemic; and in times of national disasters and civil emergencies, their efforts saved lives and property,” said President Kenyatta.

    He appreciated the Chief of the Defense Forces, General Robert Kibochi, the Service Commanders and all officers serving in the senior ranks of the armed forces for their outstanding stewardship of the KDF.

    Highlighting steps taken to modernize the KDF, the president said the government has invested heavily in officer training, providing state-of-the-art equipment, improving healthcare facilities, accommodation, pay and general terms and conditions of service for the armed forces.

    "Over the past nine years, in recognition of the importance of peace and security to the realization of our development agenda, we have undertaken the most significant and expansive modernization of our military in our nation's history," the president said. .

    In addition, President Kenyatta said that the government has enacted a law that creates guarantees for KDF officers in their retirement and also facilitates the integration of the disabled or seriously injured in the performance of their duties.

    "To seal this guarantee, on June 15 of this year, I had the rare honor and privilege of signing the Military Veterans Act into law," he said.

    Noting that the political pace towards the upcoming elections is reaching a fever pitch, President Kenyatta urged all Kenyans to reflect on the sacrifice made by KDF officers in their service and in defense of Kenya by putting the interests of the country in everything they do.

    “Over the last 9 years, some of the most harrowing decisions were the ones that would put our soldiers in harm's way.

    “These were difficult decisions because the officers are our children and when they go out on any mission in defense of our borders at home or abroad, I knew very well that they would either return raising our national flag; or return wrapped in our national flag”, said the President.

    Present at the ceremony were Cabinet Secretary for Defense Eugene Wamalwa, Chief of Defense Forces General Robert Kibochi, Commander of the Kenya Army, Lieutenant General Walter R. Koipaton, Commander of the Kenya Air Force , Maj. Gen. John Omenda, Kenyan Navy Commander Maj. Gen. Jimson Mutai, and RTS Commander Brig Paul Njema.

    Others were the Inspector General of Police, Hillary Mutyambai, Governor Jackson Mandago and his counterpart from Elgeyo Marakwet, Alex Tolgos, among others.

    Earlier, when he arrived at the Recruit Training School, the Head of State officially opened the new state-of-the-art Eldoret Regional Hospital which will serve the health needs of officers serving in the North Rift, Western and Nyanza regions.

  •  The National Pension Commission PenCom says Pension Fund Administrators PFAs registered 93 114 Retirement Savings Accounts RSAs in the first quarter Q1 of 2022 This was obtained from the organisation s official website on Friday in Abuja According to the report the PFAs registered 93 114 RSAs during the quarter under review which brought the cumulative RSA registrations from inception to 9 621 979 as at March 31 The report stated that the RSA Transfer System RTS was a total of 7 663 RSA holders initiated RSA transfers in the first RSA Transfer Quarter of 2022 which was concluded in the first week of April 2022 This covered RSA transfer requests submitted by PFAs between January 1 and March 31 which were eligible for RSA transfer in the first quarter of 2022 Out of the total RSA transfers initiated 5 543 RSAs were transferred to their new PFAs along with their associated pension assets while 2 120 transfer requests failed The failed submissions by PFAs could be attributed to their internal processes as all the PFAs recorded some failed RSA transfer request submissions the report said Also the report stated that PenCOM received an application from the Nigeria Social Insurance Trust Fund NSITF to transfer NSITF contributions on behalf of 218 NSITF contributors during the quarter under review Approval was granted to transfer N11 53 million to the RSAs of 213 contributors on a similar note the commission approved monthly pensions in the sum of N40 47 million to 2 304 NSITF pensioners it said The report also stated that the compliance by State Governments to the status of Implementation of the CPS and other Schemes as at Q1 2022 impressive 25 States of the Federation had enacted pension laws on the CPS while eight states are at the bill stage four states adopted the Contributory Defined Benefits Scheme CDBS PenCom received 11 200 applications from private sector organisations for the issuance of Pension Clearance Certificates PCCs Out of this number PCCs were issued to 10 541 organisations while 659 applications were in the approval process as at March 31 The records showed that the 10 541 organisations actions had remitted a total sum of N59 39 billion into the RSAs of their employees totaling 45 170 it added NAN
    PFAs register 93,114 RSAs in Q1- PenCom
     The National Pension Commission PenCom says Pension Fund Administrators PFAs registered 93 114 Retirement Savings Accounts RSAs in the first quarter Q1 of 2022 This was obtained from the organisation s official website on Friday in Abuja According to the report the PFAs registered 93 114 RSAs during the quarter under review which brought the cumulative RSA registrations from inception to 9 621 979 as at March 31 The report stated that the RSA Transfer System RTS was a total of 7 663 RSA holders initiated RSA transfers in the first RSA Transfer Quarter of 2022 which was concluded in the first week of April 2022 This covered RSA transfer requests submitted by PFAs between January 1 and March 31 which were eligible for RSA transfer in the first quarter of 2022 Out of the total RSA transfers initiated 5 543 RSAs were transferred to their new PFAs along with their associated pension assets while 2 120 transfer requests failed The failed submissions by PFAs could be attributed to their internal processes as all the PFAs recorded some failed RSA transfer request submissions the report said Also the report stated that PenCOM received an application from the Nigeria Social Insurance Trust Fund NSITF to transfer NSITF contributions on behalf of 218 NSITF contributors during the quarter under review Approval was granted to transfer N11 53 million to the RSAs of 213 contributors on a similar note the commission approved monthly pensions in the sum of N40 47 million to 2 304 NSITF pensioners it said The report also stated that the compliance by State Governments to the status of Implementation of the CPS and other Schemes as at Q1 2022 impressive 25 States of the Federation had enacted pension laws on the CPS while eight states are at the bill stage four states adopted the Contributory Defined Benefits Scheme CDBS PenCom received 11 200 applications from private sector organisations for the issuance of Pension Clearance Certificates PCCs Out of this number PCCs were issued to 10 541 organisations while 659 applications were in the approval process as at March 31 The records showed that the 10 541 organisations actions had remitted a total sum of N59 39 billion into the RSAs of their employees totaling 45 170 it added NAN
    PFAs register 93,114 RSAs in Q1- PenCom
    Economy6 months ago

    PFAs register 93,114 RSAs in Q1- PenCom

    The National Pension Commission (PenCom) says  Pension Fund Administrators (PFAs) registered 93,114 Retirement Savings Accounts (RSAs), in the first quarter (Q1) of 2022.

    This was obtained from the organisation’s official website on Friday in Abuja.

    According to the report, the PFAs registered 93,114 RSAs during the quarter under review, which brought the cumulative RSA registrations from inception, to 9,621,979 as at March 31.

    The report stated that the RSA Transfer System (RTS), was a total of 7,663 RSA holders initiated RSA transfers, in the first RSA Transfer Quarter of 2022, which was concluded in the first week of April 2022.

    “ This covered RSA transfer requests, submitted by PFAs between  January 1, and  March 31, which were eligible for RSA transfer in the first quarter of 2022.

    “ Out of the total RSA transfers initiated, 5,543 RSAs were transferred to their new PFAs, along with their associated pension assets, while 2,120 transfer requests failed.

    “ The failed submissions by PFAs could be attributed to their internal processes, as all the PFAs recorded some failed RSA transfer request submissions,”  the report said.

    Also, the report stated that PenCOM received an application from the Nigeria Social Insurance Trust Fund (NSITF), to transfer NSITF contributions, on behalf of 218 NSITF contributors during the quarter under review.

    “ Approval was granted to transfer N11.53 million to the RSAs of 213 contributors; on a similar note, the commission approved monthly pensions in the sum of N40.47 million to 2,304 NSITF pensioners,” it said

    The report also stated that the compliance by State Governments to the status of Implementation of the CPS and other Schemes as at Q1 2022 impressive.

    “ 25 States of the Federation had enacted pension laws on the CPS, while eight states are at the bill stage, four states adopted the Contributory Defined Benefits Scheme (CDBS).”

    PenCom  received 11,200 applications from private sector organisations for the issuance of Pension Clearance Certificates (PCCs).

    “ Out of this number, PCCs were issued to 10,541 organisations, while 659 applications were in the approval process as at March 31.

    “ The records showed that the 10,541 organisations actions had remitted a total sum of N59,39 billion into the RSAs of their employees, totaling 45,170,” it added.

    (NAN)

  •  The World Health Organisation s WHO says global health recorded achievements in spite of the COVID 19 pandemic This is according to a WHO 2020 to 2021 Results Report released on Tuesday in Geneva ahead of the World Health Assembly scheduled to hold from May 22 to May 26 The report detailed many accomplishments which include the delivery of more than 1 4 billion vaccine doses via the COVAX facility the recommendation for broad use of the world s first malaria vaccine and WHO s response to some 87 health emergencies including COVID 19 The WHO said that during from 2020 to 2021 it led the largest ever global response to a health crisis working with 1600 technical and operational partners It said that the organization helped galvanise the biggest fastest and most complex vaccination drive in history and also spent 1 7 billion dollars on essential supplies to the COVID 19 response Dr Tedros Adhanom Ghebreyesus WHO Director General said that WHO responded to the most severe global health crisis in a century He added that WHO has also continued to support all the Member States in addressing many other threats to health in spite of squeezed budgets and disrupted services As the world continues to respond to and recover from the pandemic in the years ahead WHO s priority is to invest even more resources for our work in countries where it matters most Ensuring WHO has sustainable predictable and flexible financing is essential for fulfilling our mission to promote health keep the world safe and serve the vulnerable he said Ghebreyesus said that the ACT A partnership delivered more than one billion COVID 19 vaccine doses by January 2022 According to him the global rollout of crucial health materials included nearly 500 million dollars worth of personal protective equipment 187 million dollars in oxygen supplies 4 8 million dollars in treatments and 110 million diagnostic tests He said however much remains to be done for the world to get on track for WHO s target of each country vaccinating 70 per cent of its population by July 2022 The results report revealed noteworthy achievements beyond the pandemic Mandatory policies prohibiting the use of trans fatty acids a hazardous food compound linked to cardiovascular disease are in effect for 3 2 billion people in 58 countries The world health body said among these countries 40 have best practice policies including Brazil Peru Singapore Turkey and the UK WHO s REPLACE initiative aims for a world free of trans fats by the end of 2023 Thanks to implementation of measures mandated by WHO s Framework Convention on Tobacco Control tobacco use is decreasing in 150 countries saving lives and livelihoods Due to efforts to scale up life saving interventions guided by WHO guidelines 15 countries have achieved elimination of mother to child transmission of HIV syphilis And WHO s recommendation of widespread use of the world s first malaria vaccine RTS S has been delivered to over 1 million children It is expected to save 40 000 to 80 000 lives a year when used with other malaria control interventions it said The report demonstrates WHO s crucial role as the world s global health guardian speaking up for health equity in a world of widening inequalities It said that the grave costs of the pandemic were felt everywhere The report portrayed a world which is clearly further off track to reach crucial global health goals Due to myriad disruptions caused by the COVID 19 pandemic countries have fallen behind on WHO s Triple Billion targets that provide critical pathways to attain the Sustainable Development Goals SDGs by 2030 it said It said that progress on Universal Health Coverage and healthier populations are at about one quarter or less the pace needed to reach the Sustainable Development Goals by 2030 According to it no country was fully prepared for a pandemic of such scale It said that COVID 19 also caused huge disruptions to health services It said that 117 of 127 countries surveyed reported disruption to at least one essential health service because of COVID whilst the average disruption across those countries was a staggering 45 per cent It said going forward fulfilling the triple billion targets will be WHO s overriding goal as a measurable means of reducing health equity gaps The Results Report details WHO s efforts towards transparency and accountability providing details of expenditure The WHO Programme Budget for 2020 2021 was 5 840 4 million dollars In fact financing reached 7 916 million dollars due to COVID 19 emergency operations The surplus was thanks to the generosity of donors including 12 Member States which contributed approximately 71 per cent of the total financing it said It said that the largest share of WHO financing was earmarked by donors through specified voluntary contributions Flexible funds constituted only 20 per cent of total financing in 2020 2021 it said According to it if WHO is to play its full role in achieving the SDGs delivering on universal health coverage reducing the burden of ill health and protecting 1 billion more people from health emergencies It said that the share of regular stable predictable financing must increase NAN
    Global health recorded achievements inspite of COVID-19, says WHO
     The World Health Organisation s WHO says global health recorded achievements in spite of the COVID 19 pandemic This is according to a WHO 2020 to 2021 Results Report released on Tuesday in Geneva ahead of the World Health Assembly scheduled to hold from May 22 to May 26 The report detailed many accomplishments which include the delivery of more than 1 4 billion vaccine doses via the COVAX facility the recommendation for broad use of the world s first malaria vaccine and WHO s response to some 87 health emergencies including COVID 19 The WHO said that during from 2020 to 2021 it led the largest ever global response to a health crisis working with 1600 technical and operational partners It said that the organization helped galvanise the biggest fastest and most complex vaccination drive in history and also spent 1 7 billion dollars on essential supplies to the COVID 19 response Dr Tedros Adhanom Ghebreyesus WHO Director General said that WHO responded to the most severe global health crisis in a century He added that WHO has also continued to support all the Member States in addressing many other threats to health in spite of squeezed budgets and disrupted services As the world continues to respond to and recover from the pandemic in the years ahead WHO s priority is to invest even more resources for our work in countries where it matters most Ensuring WHO has sustainable predictable and flexible financing is essential for fulfilling our mission to promote health keep the world safe and serve the vulnerable he said Ghebreyesus said that the ACT A partnership delivered more than one billion COVID 19 vaccine doses by January 2022 According to him the global rollout of crucial health materials included nearly 500 million dollars worth of personal protective equipment 187 million dollars in oxygen supplies 4 8 million dollars in treatments and 110 million diagnostic tests He said however much remains to be done for the world to get on track for WHO s target of each country vaccinating 70 per cent of its population by July 2022 The results report revealed noteworthy achievements beyond the pandemic Mandatory policies prohibiting the use of trans fatty acids a hazardous food compound linked to cardiovascular disease are in effect for 3 2 billion people in 58 countries The world health body said among these countries 40 have best practice policies including Brazil Peru Singapore Turkey and the UK WHO s REPLACE initiative aims for a world free of trans fats by the end of 2023 Thanks to implementation of measures mandated by WHO s Framework Convention on Tobacco Control tobacco use is decreasing in 150 countries saving lives and livelihoods Due to efforts to scale up life saving interventions guided by WHO guidelines 15 countries have achieved elimination of mother to child transmission of HIV syphilis And WHO s recommendation of widespread use of the world s first malaria vaccine RTS S has been delivered to over 1 million children It is expected to save 40 000 to 80 000 lives a year when used with other malaria control interventions it said The report demonstrates WHO s crucial role as the world s global health guardian speaking up for health equity in a world of widening inequalities It said that the grave costs of the pandemic were felt everywhere The report portrayed a world which is clearly further off track to reach crucial global health goals Due to myriad disruptions caused by the COVID 19 pandemic countries have fallen behind on WHO s Triple Billion targets that provide critical pathways to attain the Sustainable Development Goals SDGs by 2030 it said It said that progress on Universal Health Coverage and healthier populations are at about one quarter or less the pace needed to reach the Sustainable Development Goals by 2030 According to it no country was fully prepared for a pandemic of such scale It said that COVID 19 also caused huge disruptions to health services It said that 117 of 127 countries surveyed reported disruption to at least one essential health service because of COVID whilst the average disruption across those countries was a staggering 45 per cent It said going forward fulfilling the triple billion targets will be WHO s overriding goal as a measurable means of reducing health equity gaps The Results Report details WHO s efforts towards transparency and accountability providing details of expenditure The WHO Programme Budget for 2020 2021 was 5 840 4 million dollars In fact financing reached 7 916 million dollars due to COVID 19 emergency operations The surplus was thanks to the generosity of donors including 12 Member States which contributed approximately 71 per cent of the total financing it said It said that the largest share of WHO financing was earmarked by donors through specified voluntary contributions Flexible funds constituted only 20 per cent of total financing in 2020 2021 it said According to it if WHO is to play its full role in achieving the SDGs delivering on universal health coverage reducing the burden of ill health and protecting 1 billion more people from health emergencies It said that the share of regular stable predictable financing must increase NAN
    Global health recorded achievements inspite of COVID-19, says WHO
    General news7 months ago

    Global health recorded achievements inspite of COVID-19, says WHO

    The World Health Organisation’s (WHO) says global health recorded achievements in spite of the COVID-19 pandemic.

    This is according to a WHO 2020 to 2021 Results Report released on Tuesday in Geneva ahead of the World Health Assembly scheduled to hold from May 22 to May 26.

    The report detailed many accomplishments which include the delivery of more than 1.4 billion vaccine doses via the COVAX facility, the recommendation for broad use of the world’s first malaria vaccine and WHO’s response to some 87 health emergencies, including COVID-19.

    The WHO said that during  from 2020 to 2021, it led the largest-ever global response to a health crisis, working with 1600 technical and operational partners.

    It said that the organization helped galvanise the biggest, fastest and most complex vaccination drive in history and also spent 1.7 billion dollars on essential supplies to the COVID-19 response.

    Dr Tedros Adhanom Ghebreyesus, WHO Director-General, said that WHO responded to the most severe global health crisis in a century.

    He added that WHO has also continued to support all the Member States in addressing many other threats to health, in spite of squeezed budgets and disrupted services.

    “As the world continues to respond to and recover from the pandemic in the years ahead, WHO’s priority is to invest even more resources for our work in countries, where it matters most.

    “Ensuring WHO has sustainable, predictable and flexible financing is essential for fulfilling our mission to promote health, keep the world safe and serve the vulnerable”, he said.

    Ghebreyesus said that the ACT-A partnership delivered more than one billion COVID-19 vaccine doses by January 2022.

    According to him, the global rollout of crucial health materials included nearly 500 million dollars’ worth of personal protective equipment; 187 million dollars in oxygen supplies, 4.8 million dollars in treatments and 110 million diagnostic tests.

    He said however, much remains to be done for the world to get on track for WHO’s target of each country vaccinating 70 per cent of its population by July 2022.

    The results report revealed noteworthy achievements beyond the pandemic.

    Mandatory policies prohibiting the use of trans fatty acids (a hazardous food compound linked to cardiovascular disease), are in effect for 3.2 billion people in 58 countries.

    The world health body said among these countries, 40 have best practice policies, including  Brazil, Peru, Singapore, Turkey and the UK.

    “WHO’s REPLACE initiative aims for a world free of trans-fats by the end of 2023.

    “Thanks to implementation of measures mandated by WHO’s Framework Convention on Tobacco Control, tobacco use is  decreasing in 150 countries saving lives and livelihoods.

    “Due to efforts to scale up life-saving interventions guided by WHO  guidelines, 15 countries have achieved elimination of mother-to-child transmission of HIV syphilis.

    “And WHO’s recommendation of widespread use of the world’s first malaria vaccine (RTS,S) has been delivered to over 1 million children.

    “ It is expected to save 40 000 to 80 000 lives a year, when used with other malaria control interventions,’’ it said.

    The report demonstrates WHO’s crucial role as the world’s global health guardian, speaking up for health equity in a world of widening inequalities.

    It said that the grave costs of the pandemic were felt everywhere.

    The report portrayed a world which is clearly further off track to reach crucial global health goals.

    “Due to myriad disruptions caused by the COVID-19 pandemic, countries have fallen behind on WHO’s “Triple Billion targets” that provide critical pathways to attain the Sustainable Development Goals (SDGs) by 2030,’’ it said.

    It said that progress on Universal Health Coverage and healthier populations are at about one quarter or less the pace needed to reach the Sustainable Development Goals by 2030.

    According to it, no country was fully prepared for a pandemic of such scale.

    It said that COVID-19 also caused huge disruptions to health services.

    It said that 117 of 127 countries surveyed reported disruption to at least one essential health service because of COVID, whilst the average disruption across those countries was a staggering 45 per cent.

    It said going forward, fulfilling the triple billion targets will be WHO’s overriding goal, as a measurable means of reducing health equity gaps.

    The Results Report details WHO’s efforts towards transparency and accountability, providing details of expenditure.

    The WHO Programme Budget for 2020-2021 was 5 840.4 million dollars.

    ` In fact, financing reached 7 916 million dollars, due to COVID-19 emergency operations.

    “The surplus was thanks to the generosity of donors, including 12 Member States which contributed approximately 71 per cent of the total financing,’’ it said.

    It said that the largest share of WHO financing was earmarked by donors through specified voluntary contributions.

    Flexible funds constituted only 20 per cent of total financing in 2020-2021,’’ it said.

    According to it, if WHO is to play its full role in achieving the SDGs, delivering on universal health coverage, reducing the burden of ill health and protecting 1 billion more people from health emergencies.

    It said that the share of regular, stable, predictable financing must increase. (

    (NAN)

latest nigerian news headlines wwwbet9jamobile alfijir hausa website shortner Bitchute downloader